VRDN Viridian Therapeutics, Inc./DE

Fundamentals / CIK 0001590750 / USD

Viridian Therapeutics, Inc./DE reported $26.31M in revenue and a net loss of $453.6M for the trailing twelve months ended September 30, 2026 (down 63.5% year over year), with a -1781.4% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open VRDN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$106.0M$53.00M$0-$326.4MFY 2016 Revenue: $3.48MFY 2016 Net Income: -$17.27M2016FY 2017 Revenue: $4.00MFY 2017 Net Income: -$26.51M2017FY 2018 Revenue: $8.39MFY 2018 Net Income: -$32.70M2018FY 2019 Revenue: $4.46MFY 2019 Net Income: -$41.87M2019FY 2020 Revenue: $1.05MFY 2020 Net Income: -$110.7M2020FY 2021 Revenue: $2.96MFY 2021 Net Income: -$79.41M2021FY 2022 Revenue: $1.77MFY 2022 Net Income: -$129.9M2022FY 2023 Revenue: $314KFY 2023 Net Income: -$237.7M2023FY 2024 Revenue: $302KFY 2024 Net Income: -$269.9M2024FY 2025 Revenue: $70.85MFY 2025 Net Income: -$342.6M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $70.85M $302K $314K $1.77M $2.96M $1.05M $4.46M $8.39M $4.00M $3.48M
Cost of Revenue -- -- -- -- -- -- -- -- -- $2.55M
Gross Profit -- -- -- -- -- -- -- -- -- $929K
Research & Development $338.9M $238.3M $159.8M $100.9M $56.89M $28.30M $34.79M $30.42M $19.62M $13.69M
Selling, General & Admin $95.31M $61.08M $95.00M -- -- -- -- -- -- $8.44M
Total Operating Expenses $434.2M $299.3M $254.8M $136.1M $82.69M $111.4M $46.44M $41.47M $30.54M $20.46M
Operating Income -$363.4M -$299.0M -$254.4M -$134.3M -$79.73M -$110.4M -$41.98M -$33.08M -$26.53M -$16.99M
EBITDA -$362.9M -$298.5M -$253.9M -$134.0M -$79.61M -$110.1M -$41.69M -$32.80M -$26.22M -$16.65M
Interest Income $27.40M $31.60M $18.24M -- -- -- -- -- -- --
Interest Expense $4.95M $2.20M $1.33M $500K $3.0K $508K $835K $873K $383K $95K
Income Tax Expense $0 -- -- -- -- -- -- -- -- --
Net Income -$342.6M -$269.9M -$237.7M -$129.9M -$79.41M -$110.7M -$41.87M -$32.70M -$26.51M -$17.27M
Basic EPS -- -- -$5.31 -$4.05 -$6.66 -$31.13 -$20.04 -$1.10 -$1.38 -$28.21
Diluted EPS -- -- -$5.31 -$4.05 -$6.66 -$31.13 -$20.04 -$1.10 -$1.38 -$28.21
Basic Shares Outstanding -- -- 44.8M 32.1M 11.9M 3.6M 2.1M 29.6M 19.2M 614.0K
Diluted Shares Outstanding -- -- 44.8M 32.1M 11.9M 3.6M 2.1M 29.6M 19.2M 614.0K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $25.75M $284K $141K $132K $70.57M $75K $72K $72K
Cost of Revenue $1.53M -- -- -- $0 -- -- --
Gross Profit $24.23M -- -- -- $70.57M -- -- --
Research & Development $70.09M $71.58M $77.63M $89.21M $86.26M $86.63M $76.83M $71.96M
Selling, General & Admin $57.61M $54.98M $38.68M $33.67M $24.32M $20.22M $17.10M --
Total Operating Expenses -- $126.6M $116.3M $122.9M $110.6M $106.8M $93.94M $87.54M
Operating Income -$103.5M -$126.3M -$116.2M -$122.7M -$40.01M -$106.8M -$93.87M -$87.47M
EBITDA -$103.1M -$126.2M -$116.0M -$122.6M -$39.90M -$106.7M -$93.75M -$87.35M
Interest Income $9.54M $8.49M $7.87M $7.79M $5.52M $6.55M $7.54M --
Interest Expense $9.27M $8.31M $3.46M $3.28M $560K $514K $550K $517K
Net Income -$101.2M -$127.1M -$104.9M -$120.4M -$34.60M -$100.7M -$86.91M -$79.72M
Diluted Shares Outstanding -- -- -- -- 81.8M 81.6M 81.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $212.4M -- -- -- -- -- -- $32.61M $47.44M $22.10M
Short-Term Investments $662.3M $618.0M $374.5M $269.0M $154.7M $81.74M $2.00M $29.88M $0 --
Cash & Short-Term Investments $874.7M $717.6M $477.4M $424.6M $197.0M $127.6M $26.80M $62.48M $47.44M $22.10M
Accounts Receivable, Net $0 -- -- -- -- -- $108K $24K $1.46M $20K
Inventory $0 -- -- -- -- -- -- -- -- $64K
Total Current Assets $894.2M $738.5M $486.5M $431.2M $200.2M $129.6M $29.74M $65.37M $51.87M $23.88M
Property, Plant & Equipment, Net $1.23M $1.24M $1.67M $1.33M $375K $309K $523K $727K $563K $625K
Intangible Assets $0 -- -- -- -- -- -- -- -- --
Long-Term Investments -- -- -- -- -- -- $0 -- -- --
Other Non-Current Assets $1.54M $501K $604K $982K $1.49M $1.0K $0 $50K $50K $258K
Total Non-Current Assets $5.18M $3.94M $3.95M $3.92M $3.55M $1.64M $523K $777K $613K $883K
Total Assets $899.4M $742.4M $490.4M $435.1M $203.7M $131.3M $30.26M $66.15M $52.48M $24.76M
Accounts Payable $8.68M $2.14M $2.24M $14.23M $2.33M $670K $1.10M $571K $906K $1.01M
Short-Term Debt -- $0 $0 -- -- -- -- -- -- --
Deferred Revenue (Current) $367K $288K $288K $288K $289K $301K $0 -- -- --
Other Current Liabilities -- -- -- -- -- -- -- -- -- $4.0K
Total Current Liabilities $70.70M $47.87M $26.64M $33.35M $13.64M $10.67M $10.18M $6.73M $3.90M $6.88M
Long-Term Debt -- $20.58M $20.20M $4.64M $0 -- $7.67M $10.00M $10.00M --
Deferred Revenue (Non-Current) -- $284K $573K $861K $1.15M -- -- -- -- --
Other Non-Current Liabilities $2.34M $2.31M $989K $1.17M $1.21M $43K $0 $66K $152K $0
Total Non-Current Liabilities $106.6M $22.89M $21.77M $6.68M $2.36M $544K $4.33M $8.07M $10.07M $2.82M
Total Liabilities $177.3M $70.76M $48.40M $40.03M $15.99M $11.22M $14.51M $14.80M $13.97M $9.71M
Total Debt (incl. Leases) $2.71M $23.12M $22.04M $6.37M $1.72M $455K $7.67M $10.00M $10.00M --
Common Stock $1.02M $810K $540K $414K $239K $42K $23K $308K $226K $8.0K
Retained Earnings -$1.34B -$995.9M -$725.9M -$488.2M -$358.3M -$278.9M -$168.2M -$126.3M -$93.59M -$67.08M
Accumulated Other Comp. Income $447K -$10K $338K -$390K -$157K -$8.0K $0 -$3.0K $0 --
Total Stockholders' Equity $722.2M $671.6M $442.0M $395.1M $187.7M $120.0M $15.75M $51.34M $38.51M -$61.92M
Total Equity $722.2M $671.6M $442.0M $395.1M $187.7M $120.0M $15.75M $51.34M $38.51M -$61.92M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $172.9M -- -- $212.4M $169.6M -- -- --
Short-Term Investments $782.3M $816.5M $585.8M $662.3M $321.3M $446.0M $520.4M $618.0M
Cash & Short-Term Investments $955.2M $981.5M $762.2M $874.7M $490.9M $563.4M $636.6M $717.6M
Accounts Receivable, Net $29.78M -- -- $0 -- -- -- --
Inventory $85K -- -- $0 -- -- -- --
Total Current Assets $1.01B $1.08B $784.7M $894.2M $571.9M $578.8M $657.2M $738.5M
Property, Plant & Equipment, Net $2.97M $2.77M $1.13M $1.23M $1.12M $1.09M $1.16M $1.24M
Intangible Assets $9.79M $10.00M -- $0 -- -- -- --
Other Non-Current Assets $131K $1.11M $888K $1.54M $1.52M $506K $489K $501K
Total Non-Current Assets $15.54M $15.96M $4.27M $5.18M $5.22M $3.57M $3.74M $3.94M
Total Assets $1.03B $1.10B $789.0M $899.4M $577.1M $582.3M $661.0M $742.4M
Accounts Payable $9.30M $8.65M $13.31M $8.68M $10.06M $8.52M $3.89M $2.14M
Short-Term Debt -- -- -- -- -- $8.44M -- $0
Deferred Revenue (Current) -- $181K $274K $367K $372K $288K $288K $288K
Total Current Liabilities $70.05M $63.79M $51.80M $70.70M $50.70M $52.59M $33.73M $47.87M
Long-Term Debt -- -- -- -- $20.89M $12.35M $20.68M $20.58M
Deferred Revenue (Non-Current) -- -- -- -- -- $140K $212K $284K
Other Non-Current Liabilities $2.23M $1.85M $2.18M $2.34M $2.58M $2.08M $1.88M $2.31M
Total Non-Current Liabilities $377.9M $371.3M $101.2M $106.6M $23.47M $14.57M $22.78M $22.89M
Total Liabilities $448.0M $435.1M $153.0M $177.3M $74.17M $67.16M $56.51M $70.76M
Total Debt (incl. Leases) $806K $722K $738K $2.71M $23.78M $23.08M $23.11M $23.12M
Common Stock $1.14M $1.13M $1.02M $1.02M $822K $817K $816K $810K
Retained Earnings -$1.67B -$1.57B -$1.44B -$1.34B -$1.22B -$1.18B -$1.08B -$995.9M
Accumulated Other Comp. Income -$2.20M -$1.15M -$558K $447K $363K $69K $245K -$10K
Total Stockholders' Equity $580.7M $662.1M $636.0M $722.2M $503.0M $515.2M $604.5M $671.6M
Total Equity $580.7M $662.1M $636.0M $722.2M $503.0M $515.2M $604.5M $671.6M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$342.6M -$269.9M -$237.7M -$129.9M -$79.41M -$110.7M -$41.87M -$32.70M -$26.51M -$17.27M
Depreciation & Amortization $460K $540K $522K $255K $120K $239K $288K $281K $308K $341K
Stock-Based Compensation $44.30M $42.15M $67.17M $19.77M $14.46M $3.65M $3.97M $3.68M $2.41M $198K
Change in Receivables -- -- -- -- -- $99K -$84K $1.43M -$1.44M -$20K
Change in Inventory -- -- -- -- -- -- -- -- -- $123K
Change in Payables $6.56M -$73K -$12.04M $11.52M $1.66M -$426K $525K -$335K -$101K $292K
Operating Cash Flow -$276.4M -$232.3M -$184.2M -$93.84M -$54.58M -$29.78M -$36.06M -$26.84M -$28.17M -$14.76M
Capital Expenditure -$495K -$511K -$898K -$797K -$338K -$42K -$84K -$445K -$246K -$250K
Free Cash Flow -$276.9M -$232.8M -$185.1M -$94.64M -$54.92M -$29.82M -$36.14M -$27.29M -$28.41M -$15.01M
Purchases of Investments -$579.3M -$695.1M -$407.9M -$223.3M -$188.4M -$81.81M -$32.69M -$62.46M $0 -$1.00M
Sales & Maturities of Investments -- -- -- -- $114.4M $2.00M -- -- -- --
Investing Cash Flow -$37.56M -$228.7M -$94.25M -$115.1M -$74.29M -$50.48M $28.23M -$29.91M $1.03M -$250K
Common Stock Issued $63.15M $69.91M $15.26M $291.9M $114.2M $0 $2.28M $44.53M -- --
Share Repurchases -- -- -- -- -- -- -- -- -- -$2.0K
Financing Cash Flow $426.7M $457.7M $225.7M $322.2M $125.3M $101.3M $70K $41.92M $52.47M $15.87M
Net Change in Cash $112.8M -$3.23M -$52.75M $113.3M -$3.60M $21.05M -$7.76M -$14.84M $25.34M --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$101.2M -$127.1M -$104.9M -$120.4M -$34.60M -$100.7M -$86.91M -$79.72M
Depreciation & Amortization $343K $117K $121K $120K $110K $113K $117K $123K
Stock-Based Compensation $17.23M $16.98M $13.39M $11.99M $11.25M $10.84M $10.22M $8.97M
Change in Payables $1.19M -$5.20M $4.63M -$1.38M $1.55M $4.63M $1.76M -$3.92M
Operating Cash Flow -$92.77M -$105.3M -$119.7M -$23.75M -$84.61M -$75.37M -$92.65M -$73.33M
Capital Expenditure -$370K -$1.31M -$23K -$240K -$127K -$42K -$86K -$114K
Free Cash Flow -$93.14M -$106.6M -$119.7M -$23.99M -$84.74M -$75.42M -$92.74M -$73.45M
Purchases of Investments -$175.6M -$378.7M -$91.32M -$438.2M -$14.09M -$55.76M -$71.24M -$181.8M
Investing Cash Flow $24.34M -$231.2M $77.26M -$339.4M $126.1M $75.72M $100.1M -$62.91M
Common Stock Issued $0 $0 $0 $48.24M $9.96M $1.0K $4.94M $33.65M
Financing Cash Flow $77.61M $325.1M $6.36M $405.9M $10.86M $764K $9.21M $35.52M
Net Change in Cash $9.17M -$11.36M -$36.04M $42.73M $52.32M $1.11M $16.62M -$100.7M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- -- -- -- -- -- -- 26.7%
Operating Margin -512.9% -99018.2% -81035.0% -7579.2% -2690.8% -10512.4% -941.0% -394.5% -662.8% -488.6%
Net Profit Margin -483.6% -89387.1% -75711.5% -7329.2% -2680.2% -10544.3% -938.6% -390.0% -662.3% -496.8%
Return on Equity (ROE) -47.4% -40.2% -53.8% -32.9% -42.3% -92.2% -265.8% -63.7% -68.8% --
Return on Assets (ROA) -38.1% -36.4% -48.5% -29.8% -39.0% -84.4% -138.4% -49.4% -50.5% -69.8%
Current Ratio 12.65x 15.43x 18.26x 12.93x 14.68x 12.14x 2.92x 9.71x 13.31x 3.47x
Quick Ratio 12.65x 14.99x 17.92x 12.73x 14.45x 11.95x 2.64x 9.28x 12.55x 3.46x
Debt to Equity 0.00x 0.03x 0.05x 0.02x 0.01x 0.00x 0.49x 0.19x 0.26x --
Revenue Growth (YoY) +23359.9% -3.8% -82.3% -40.2% +182.2% -76.5% -46.8% +109.5% +15.1% -39.1%
Gross Profit Growth (YoY) -- -- -- -- -- -- -- -- -- -71.3%
5Y Revenue / Share Growth -- -- -97.5% -73.5% -95.6% -97.2% -25.7% -99.0% -- --
10Y Revenue / Share Growth -- -- -100.0% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -1781.4% -569.7% -543.9% -512.9% -463.5% -121831.1% -111591.1% -99018.5%
Net Profit Margin -1724.1% -544.1% -508.5% -483.6% -426.6% -112806.9% -102092.4% -89387.1%
Return on Equity (ROE) -78.1% -58.4% -56.7% -47.4% -60.0% -66.8% -51.0% -40.2%
Return on Assets (ROA) -44.1% -35.3% -45.7% -38.1% -52.3% -59.1% -46.6% -36.4%
Current Ratio 14.46x 16.95x 15.15x 12.65x 11.28x 11.01x 19.49x 15.43x
Quick Ratio 14.46x 15.39x 14.71x 12.65x 9.68x 10.71x 18.88x 14.99x
Debt to Equity 0.00x 0.00x 0.00x 0.00x 0.05x 0.04x 0.04x 0.03x
Revenue Growth (YoY) -63.5% +278.7% +95.8% +83.3% +81958.1% +4.2% 0.0% 0.0%
Gross Profit Growth (YoY) -65.7% -- -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001590750) · from June 30, 2013 Data through September 30, 2026 · synced Nov 20, 2026, 05:19 UTC · Open in terminal